We learn about a nationwide clinical trial, funded by the National Institute of Aging, that's trying to determine if high doses of a synthetic form of Vitamin B1 called benfotiamine might be an effective treatment for mild cognitive impairment or early Alzheimer's Disease. Also known as thiamine, Vitamin B1 is important for brain health, and it's known that people with Alzheimer's have a thiamine deficiency.